Glutathione-dependent interaction of heavy metal compounds with multidrug resistance proteins MRP1 and MRP2

被引:23
作者
Wortelboer, Heleen M. [1 ]
Balvers, Michiel G. J. [1 ]
Usta, Mustafa [1 ]
van Bladeren, Peter J. [2 ,3 ]
Cnubben, Nicole H. P. [1 ]
机构
[1] TNO Qual Life Business Unit Biosci, NL-3700 AJ Zeist, Netherlands
[2] Univ Wageningen & Res Ctr, TNO Ctr Food Toxicol, NL-6700 EA Wageningen, Netherlands
[3] Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland
关键词
MRP1; MRP2; cisplatin; arsenic trioxide; mercury chloride; glutathione;
D O I
10.1016/j.etap.2008.02.006
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The interactions of three heavy metal-containing compounds, cisplatin (CDDP), arsenic trioxide (AS(2)O(3)), and mercury dichloride (HgCl2), with the multidrug resistance transporters MRP1 and MRP2 and the involvement of glutathione (GSH)-related processes herein were investigated. In Madin-Darby canine kidney cells stably expressing MRP1 or MRP2, viability, GSH content, calcein efflux and polarized CSH efflux were measured as a function of exposure to CDDP, As2O3 and HgCl2. In isolated S integral]9-MRP1 and S integral 9-MRP2 membrane vesicles, the interaction with MRP-associated ATPase activity was measured. In the latter model system adduct formation with GSH is not an issue. The data show that (1) CDDP interacts with both MRP1 and MRP2, and GSH appears to play no major role in this process, (2) As2O3 interacts with MRP1 and MRP2 in which process GSH seems to be essential, and (3) HgCl2 interacts with MRP1 and MRP2, either alone and/or as a metal-GSH complex. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 51 条
[21]   On-column formation of arsenic-glutathione species detected by size-exclusion chromatography in conjunction with arsenic-specific detectors [J].
Gailer, J ;
Lindner, W .
JOURNAL OF CHROMATOGRAPHY B, 1998, 716 (1-2) :83-93
[22]   Clinical perspectives on platinum resistance [J].
Giaccone, G .
DRUGS, 2000, 59 (Suppl 4) :9-17
[23]   Overexpression of glutathione S-transferase π enhances the adduct formation of cisplatin with glutathione in human cancer cells [J].
Goto, S ;
Iida, T ;
Cho, S ;
Oka, M ;
Kohno, S ;
Kondo, T .
FREE RADICAL RESEARCH, 1999, 31 (06) :549-558
[24]   MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma [J].
Guminski, AD ;
Balleine, RL ;
Chiew, YE ;
Webster, LR ;
Tapner, M ;
Farrell, GC ;
Harnett, PR ;
deFazio, A .
GYNECOLOGIC ONCOLOGY, 2006, 100 (02) :239-246
[25]   Kinetic study on the reactions of platinum drugs with glutathione [J].
Hagrman, D ;
Goodisman, J ;
Souid, AK .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) :658-666
[26]   The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation [J].
Haimeur, A ;
Conseil, G ;
Deeley, RG ;
Cole, SPC .
CURRENT DRUG METABOLISM, 2004, 5 (01) :21-53
[27]  
Hooijberg JH, 1999, CANCER RES, V59, P2532
[28]   Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells [J].
Ishikawa, T ;
Bao, JJ ;
Yamane, Y ;
Akimaru, K ;
Frindrich, K ;
Wright, CD ;
Kuo, MT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) :14981-14988
[29]  
Itoh Y, 2002, ANTICANCER RES, V22, P1649
[30]   The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic [J].
Kala, SV ;
Neely, MW ;
Kala, G ;
Prater, CI ;
Atwood, DW ;
Rice, JS ;
Lieberman, MW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33404-33408